T33 Dental Inc., founded in 2023 and based in Cambridge, Massachusetts, is an early-stage dental technology company developing a novel platform for penetrative drug and cosmetic delivery into teeth to improve oral health and sustainability in dental care. The companys innovation uses an electrokinetic device to drive therapeutic and cosmetic agentssuch as fluoride, antimicrobials, or whitening compoundsdeep into tooth enamel and dentin, going beyond surface treatments. Led by co-founders Daniel and David Lundberg, T33 Dental has received a National Science Foundation SBIR Phase I award and early venture funding from Pillar VC and other seed investors. By combining advanced delivery science with environmentally responsible, low-waste design, T33 Dental aims to make preventive and cosmetic dental treatments more effective, less invasive, and more sustain
